Review
Open access
Aug 2026
THE ROLE OF NUTRACEUTICALS IN THE MANAGEMENT OF DYSLIPIDEMIA AND THEIR EFFECTS ON LIPID METABOLISM: A SYSTEMATIC REVIEW
Dyslipidemia is one of the top modifiable causes of ASCVD‚ which is still the leading cause of death worldwide․ Statins are first line treatment‚ but potentially reversible obstacles to effective treatment include patient discontinuation‚ statin intolerance‚ concern about statin-related adverse effects‚ and residual ca...
K. Jurga, Maurycy Jabłoński, Laura Kobaka et al.
· International Journal of Inn... · 0 citations